FDA inspection
Lotus Pharmaceutical Co., Ltd.: FDA inspection ending May 31, 2019
FDA inspection 1095930 · No Action Indicated (NAI) · Nan Tou Xian
Key facts
| Inspection ID | 1095930 |
|---|---|
| Firm | Lotus Pharmaceutical Co., Ltd. |
| FEI number | 3005999589 |
| Address | Nantou County, No. 30 Chenggong 1st Rd.; Nantou City |
| City | Nan Tou Xian |
| Country | Taiwan |
| Fiscal year | 2019 |
| Inspection end date | May 31, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data